Aardvark Therapeutics, Inc.
corporate_fare Company Profile
Aardvark Therapeutics, Inc. (NASDAQ:AARD) is a publicly traded company in the Life Sciences sector. Wiseek has independently scored 26 items for AARD at importance 7 or higher on its 1–10 market-impact scale.
Recent high-impact activity:
- Aardvark Therapeutics Pauses Lead Phase 3 Drug Trial Over Cardiac Safety Signals
- Aardvark Therapeutics Pauses Key Phase 3 Trial for ARD-101 Due to Cardiac Safety Observations
- Cardiac Safety Concerns Halt Aardvark's Phase 3 Prader-Willi Trial
- Aardvark Therapeutics Establishes Dermatology Subsidiary, Appoints CEO, and Expands Executive Team
- Aardvark Therapeutics Expands Phase 3 Trial Eligibility for Lead PWS Drug ARD-101 to Younger Children
Financial Snapshot
Fiscal year ended December 31, 2025
Net Income
-$57.59M
Diluted EPS
-$2.93
Op. Cash Flow
-$54.17M
Free Cash Flow
-$54.27M
Operating Income
-$62.73M
Cash & Equivalents
$47.05M
Debt / Equity
0.00×
Shares Outstanding
21.82M sh
Source: 10-K · filed 2026-03-23 · accession 0001193125-26-119770
show_chartPrice Chart
Loading chart...
feed AARD - Filings & News (Page 2)
AARD
Mar 23, 2026, 4:05 PM EDT
Price at Filing:
$4.07
Real-time Price:
$0.9226
Change:
-$3.14 (-77%)
Market Cap:
$20.197M
AARD
Feb 27, 2026, 4:27 PM EST
Price at Filing:
$6.50
Real-time Price:
$0.9226
Change:
-$5.58 (-86%)
Market Cap:
$20.197M
AARD
Feb 27, 2026, 4:05 PM EST
Price at Filing:
$12.49
Real-time Price:
$0.9226
Change:
-$11.57 (-93%)
Market Cap:
$20.197M
AARD
Feb 12, 2026, 8:17 AM EST
Price at Filing:
$12.67
Real-time Price:
$0.9226
Change:
-$11.75 (-93%)
Market Cap:
$20.197M
AARD
Feb 10, 2026, 8:14 AM EST
Price at Filing:
$13.06
Real-time Price:
$0.9226
Change:
-$12.14 (-93%)
Market Cap:
$20.197M
AARD
Jan 12, 2026, 8:30 AM EST
Price at Filing:
$14.73
Real-time Price:
$0.9226
Change:
-$13.81 (-94%)
Market Cap:
$20.197M